Institutional Ownership
Adial Pharmaceuticals Inc
CUSIP 00688A304COM NEWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
12
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 24.2K | $43.4K |
| 2 | Manchester Capital Management LLC | 1.9K | $3.4K |
| 3 | Tower Research Capital LLC (Trc) | 1.4K | $2.4K |
| 4 | Blackrock, Inc. | 1.1K | $2.0K |
| 5 | Ubs Group AG | 542 | $970 |
| 6 | Morgan Stanley | 50 | $90 |
| 7 | Sbi Securities Co., Ltd. | 47 | $84 |
| 8 | Caitong International Asset Management Co., Ltd | 15 | $27 |
| 9 | Wells Fargo & Company/Mn | 6 | $11 |
| 10 | Northwestern Mutual Wealth Management Co | 4 | $7 |